$VKTX

$26.78▲ +0.5% YTD

11 SEC 13D/G filings tracked · Last updated Oct 14, 2026

Filing History

VKTX ▲ +0.5% - Viking Therapeutics, Inc.

CP $26.78▲ +0.5%Oct 14, 2026 · ThinkSabio Blog

$VKTX VKTX VKTK - Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesity…

News

VKTX ▼ -1.7% - Viking Therapeutics, Inc.

CP $28.04▲ -1.7%Oct 12, 2026 · ThinkSabio Blog

Still no update from Viking Therapeutics $VKTX regarding the departure of chief commercial officer Neil Aubuchon. I emailed Viking on Friday to inquir…

News

VKTX ▲ +1.3% - Viking Therapeutics, Inc.

CP $28.75▲ +1.3%Oct 7, 2026 · ThinkSabio Blog

$VKTX - Vol pop social media circulations on name…

News

VKTX ▲ +1.0% - Viking Therapeutics, Inc.

CP $29.60▲ +1.0%Oct 6, 2026 · ThinkSabio Blog

$VKTX VKTX - Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity…

News

VKTX ▼ -6.6% - Viking Therapeutics, Inc.

CP $33.23▲ -6.6%Sep 28, 2026 · ThinkSabio Blog

$VKTX VKTX - Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exerci…

News

VKTX ▼ -10.6% - Viking Therapeutics, Inc.

CP $37.24▲ -10.6%Sep 24, 2026 · ThinkSabio Blog

$VKTX - Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes…

News

VKTX ▼ -5.8% - Viking Therapeutics, Inc.

CP $38.48▲ -5.8%Sep 23, 2026 · ThinkSabio Blog

$VKTX 200 million stock offering & 200 million convertible senior notes…

News

VKTX ▼ -7.0% - Viking Therapeutics, Inc.

CP $38.00▲ -7.0%Sep 23, 2026 · ThinkSabio Blog

$VKTX - Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes…

News

VKTX ▲ +28.7% - Viking Therapeutics, Inc.

CP $38.76▲ +28.7%Sep 22, 2026 · ThinkSabio Blog

$VKTX VKTX - Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Mu…

News

VKTX ▲ +28.7% - Viking Therapeutics, Inc.

CP $38.76▲ +28.7%Sep 22, 2026 · ThinkSabio Blog

$VKTX - UP TO 97% WEIGHT LOSS MAINTAINED WITH EVERY-OTHER-WEEK DOSING FOR THREE MONTHS…

News

VKTX ▼ -0.3% - Viking Therapeutics, Inc.

CP $33.50▲ -0.3%Sep 2, 2026 · ThinkSabio Blog

$VKTX - Viking Therapeutics to Participate at Upcoming Investor Conferences…